Skip to main content
CHCRF
OTC Life Sciences

Cheelcare Announces $1.5M Private Placement Priced at 129% Premium to OTC Shares

Tom Rudovsky · Reported by TMX Newsfile
More coverage: Healthcare
Sentiment info
Positive
Importance info
9
Price
$0.655
Mkt Cap
0
52W Low
$0.655
52W High
$0.655
52W Position info
0.0% above low
Off High info
at 52W high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

CHCRF is trading near its 52-week low of $0.655 (0.0% above the low).

Summary

Cheelcare announced a non-brokered private placement to raise up to $1.5 million. Units are priced at $1.50, which is a substantial 129% premium to the current OTC share price of $0.6551. This strong investor commitment follows recent positive developments, including a new patent and record product bookings. The capital will fund continued product development and commercialization activities.

At the time of this announcement, CHCRF was trading at $0.66 on OTC in the Life Sciences sector. The 52-week trading range was $0.66 to $0.66. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: TMX Newsfile.


Price Chart

Share this article

Copied!

CHCRF - Latest Insights

CHCRF
Jul 03, 2026, 7:30 AM EDT
Source: TMX Newsfile
Importance Score:
9
Price at Filing: $0.6551
Real-time Price: $0.6551 info
Change: $0 (0%) info
Market Cap: N/A info
CHCRF
May 28, 2026, 7:30 AM EDT
Source: TMX Newsfile
Importance Score:
7
Price at Filing: $0.6551
Real-time Price: $0.6551 info
Change: $0 (0%) info
Market Cap: N/A info
CHCRF
May 11, 2026, 7:30 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $0.6551
Real-time Price: $0.6551 info
Change: $0 (0%) info
Market Cap: N/A info
CHCRF
Apr 09, 2026, 7:30 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $0.6551
Real-time Price: $0.6551 info
Change: $0 (0%) info
Market Cap: N/A info